Abstract
This study predicts the maximum hospital demand and number of infections for the LMICs in the first wave of COVID-19 pandemic. The epidemic is estimated to impose health care burden excessively exceeding the current capacity of hospitals in many LMICs, especially in Honduras, Central African Republic and Colombia.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study is funded by Strategic Priority CAS Project (grant XDB38040200), National Natural Science Foundation of China (grant 71950011, 11871447, 71991464/71991460) and National Key Research and Development Program of China (grant 2018AAA0101001).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
We used public secondary deidentified data in this study that did not require institutional review board approval or inform consent.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
